Hua Xing Zhu
Algemeen Directeur bij NOVOPROTEIN SCIENTIFIC INC.
Profiel
Hua Xing Zhu is the founder and currently holds the position of Chairman & General Manager at Novoprotein Scientific (Shanghai), Inc. He founded Suzhou Novoprotein Scientific Co., Ltd.
in 2009 and holds the position of Chairman & General Manager.
Dr. Zhu received his doctorate degree from Fudan University in 2005.
Actieve functies van Hua Xing Zhu
| Bedrijven | Functie | Begin |
|---|---|---|
| NOVOPROTEIN SCIENTIFIC INC. | Algemeen Directeur | 07-09-2009 |
Novoprotein Scientific (Shanghai), Inc.
 Novoprotein Scientific (Shanghai), Inc. Internet RetailRetail Trade Novoprotein Scientific (Shanghai), Inc. is a high-tech enterprise specializing in protein technology. Novoprotein Scientific (Shanghai is based in Shanghai, CN, with R&D and production bases in other locations, including Heze. The Chinese company's main focus is on biopharmaceuticals, in vitro diagnosis, vaccine drugs, and basic research on life sciences. The private company offers solutions such as targets and factor proteins, restructuring antibodies, enzymes, and reagents, and provide related technical services. The company was founded in 2009, and the CEO is Hua Xing Zhu. | Algemeen Directeur | - |
Opleiding van Hua Xing Zhu
| Fudan University | Doctorate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| NOVOPROTEIN SCIENTIFIC INC. | Commercial Services |
| Bedrijven in privébezit | 1 |
|---|---|
Novoprotein Scientific (Shanghai), Inc.
Novoprotein Scientific (Shanghai), Inc. Internet RetailRetail Trade Novoprotein Scientific (Shanghai), Inc. is a high-tech enterprise specializing in protein technology. Novoprotein Scientific (Shanghai is based in Shanghai, CN, with R&D and production bases in other locations, including Heze. The Chinese company's main focus is on biopharmaceuticals, in vitro diagnosis, vaccine drugs, and basic research on life sciences. The private company offers solutions such as targets and factor proteins, restructuring antibodies, enzymes, and reagents, and provide related technical services. The company was founded in 2009, and the CEO is Hua Xing Zhu. | Retail Trade |
